Trial Profile
A Pharmacokinetic Study of S-1 in Patients with Locally Advanced Head and Neck Cancer and Renal Insufficiency
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Oct 2017
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Pharmacokinetics
- 31 Oct 2017 New trial record